Voluven Disease Interactions
There are 5 disease interactions with Voluven (hydroxyethyl starch).
Hydroxyethyl starch (applies to Voluven) coagulation disorders
Major Potential Hazard, Moderate plausibility. Applicable conditions: Coagulation Defect, Intracranial Hemorrhage
Do not use hydroxyethyl starch products with preexisting coagulation or bleeding disorders, including those patients with intracranial bleeding.
Hydroxyethyl starch (applies to Voluven) liver dysfunction
Major Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Do not use hydroxyethyl starch products in patients with severe liver disease.
Hydroxyethyl starch (applies to Voluven) renal disease
Major Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Do not use hydroxyethyl starch products in patients with renal failure with oliguria or anuria not related to hypovolemia, including those patients receiving dialysis treatment.
Hydroxyethyl starch (applies to Voluven) sepsis
Major Potential Hazard, Moderate plausibility.
Do not use hydroxyethyl starch products in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy.
Hydroxyethyl starch (applies to Voluven) volume overload
Major Potential Hazard, Moderate plausibility. Applicable conditions: Hypernatremia
Do not use hydroxyethyl starch products with severe hypernatremia or severe hyperchloremia and in clinical conditions with volume overload.
Switch to professional interaction data
Report options
More about Voluven (hydroxyethyl starch)
- Voluven consumer information
- Compare alternatives
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: plasma expanders
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Albuked
Albuked is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Albuked 25
Albuked 25 is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Albuked 5
Albuked 5 is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Albuminar-25
Albuminar-25 is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Alburx
Alburx is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Albutein
Albutein is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Buminate
Buminate is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Dextran 70 6% in 5% Dextrose
Dextran 70 6% in 5% Dextrose is used for bleeding disorder
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.